Based on prior database analyses, the frequency of the ACE II genotype within a population showed a remarkably negative association with mortality caused by SARS-CoV-2 infection, which indicated a favorable influence of the ACE II genotype on COVID-19 morbidity and outcome [29]. The gene discussed is ACE; the disease is COVID-19.